Skip to main content
ONCO logo

Onconetix, Inc.

ONCONASDAQHealthcareBiotechnology

$0.48Today:- (-)1Y −83.79%

As of Oct 16, 2026 close

Market cap
$1.23M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.54$67.30
Volume (live)
-
Avg. volume (3M)
5.93M

Onconetix (ONCO) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Onconetix used $9.68M of cash in operating activities. Free cash flow was −$9.68M. It repurchased $926.00 of its own shares.

Onconetix Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Onconetix, Inc. (ONCO) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-14.03-58.69-37.41-13.42-3.42-1.60-0.82
Depreciation & Amortization0.020.730.040.010.000.000.00
Deferred Income Tax0.00-1.05-0.010.000.00-0.290.00
Stock Based Compensation0.070.440.331.970.130.330.00
Change in Working Capital-2.42-1.541.622.561.21-0.47-0.01
Change in Accounts Receivable-0.270.12-0.060.00-0.110.00-0.01
Change in Inventory-0.07-0.06-0.320.000.000.000.00
Change in Accounts Payable-1.09-1.483.371.090.340.050.02
Change in Other Working Capital-0.40-0.12-1.371.470.07-0.52-0.02
Other Operating Activities6.6849.6121.840.200.020.290.00
Net Cash from Operating Activities-9.68-10.50-13.58-8.68-2.04-1.73-0.83
Investing Activities
Capital Expenditures0.00-0.03-0.06-0.010.00-0.010.00
Other Investing Activities0.000.00-8.59-0.020.000.000.00
Net Cash from Investing Activities0.00-0.03-8.65-0.030.00-0.010.00
Financing Activities
Debt Repayment-7.113.65-1.000.000.000.00-0.05
Common Stock Issued6.390.690.0034.870.000.000.00
Common Stock Repurchased0.000.00-0.06-0.570.000.000.00
Dividends Paid0.00-0.210.000.000.000.000.00
Other Financing Activities0.002.612.09-1.77-0.330.006.93
Net Cash from Financing Activities14.456.741.0432.53-0.330.006.88
Summary
Effect of Forex Changes on Cash-0.20-0.130.000.000.000.000.00
Net Change in Cash4.57-3.91-21.2023.82-2.38-1.746.05
Cash at Beginning of Period0.654.5525.751.934.316.050.00
Cash at End of Period5.220.654.5525.751.934.316.05
Free Cash Flow-9.68-10.52-13.64-8.68-2.05-1.74-0.83
Supplemental Disclosures
Interest Paid-0.38-----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Onconetix Cash Flow

What is Onconetix's free cash flow?

Onconetix had negative free cash flow of $9.68M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Onconetix pay dividends or buy back shares?

Yes. In fiscal 2025 Onconetix returned $926.00 in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition